| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H30O2 |
| Molecular Weight | 302.451 |
| Optical Activity | ( + ) |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
InChI
InChIKey=JRNSSSJKIGAFCT-YDSAWKJFSA-N
InChI=1S/C20H30O2/c1-18-9-6-14(21)12-13(18)4-5-15-16(18)7-10-19(2)17(15)8-11-20(19,3)22/h6,9,13,15-17,22H,4-5,7-8,10-12H2,1-3H3/t13-,15+,16-,17-,18-,19-,20-/m0/s1
| Molecular Formula | C20H30O2 |
| Molecular Weight | 302.451 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Methyl-1-testosterone(M1T)(17alpha-hydroxy-17-methyl-
5-androst-1-en-3-one) is a new designer steroid that is most likely produced to circumvent
the legal restrictions. It is advertised to be highly
anabolic and moderately androgenic and not convertible
to estrogens. However, in scientific literature, it was reported
to show anabolic properties of 25% and androgenic
properties of 50% compared with testosterone propionate
after im injection in castrated rats. In February
2006, Health Canada (Federal Department) warned consumers
not to use M1T-containing products because of
potentially serious health risks such as liver disorders and
hardening of the arteries. Since 2006, M1T is explicitly listed on the
World Anti-Doping Agency list of prohibited substances,
and therefore, its use by athletes is prohibited.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 3.0 nM [EC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sample Use Guides
For amplifying performance and physique gains, recommended dosages range from 5mg to 20mg. Dosages above 20mg is not recommended.
Route of Administration:
Oral
